Aclaris Therapeutics Inc Stock Performance
as on April 21, 2026 at 6:59 am IST
Day's Low
Day's High
$4.17$4.32
1.88%
Downside
1.65%
Upside
52 Week's Low
52 Week's High
$1.10$4.8974.24%
Downside
15.06%
Upside
Aclaris Therapeutics Inc share price movements today
- Previous Close
- $4.25
- Open
- $4.21
- Volume
- 1.5M
- Day's Low - High
- $4.17 - $4.32
- 52 Week Low - High
- $1.10 - $4.89
Aclaris Therapeutics Inc Historical Returns
- 1 Month Return
- + 15.18 %
- 3 Month Return
- -4.06 %
- 1 Year Return
- + 272.81 %
- 3 Year Return
- -53.7 %
- 5 Year Return
- -83.94 %
Aclaris Therapeutics Inc Stock Fundamentals & Key Indicators
Check Aclaris Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$514.6M
EPS (TTM)
-0.6017
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
-0.13
EBITDA
-74.0M
Revenue (TTM)
7.8M
Profit Margin
0.00%
Return On Equity TTM
-50.20%
Aclaris Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aclaris Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $514.6M | -83.94% | NA | 0.00% | |
| BUY | $41.3B | 127.64% | 133.47 | 8.45% | |
| BUY | $112.2B | 100.4% | 28.82 | 32.94% | |
| NA | $37.2B | NA | 131.65 | 5.37% | |
| BUY | $79.4B | 48.8% | 18.08 | 31.41% |
Stock Returns calculator for Aclaris Therapeutics Inc Stock including INR - Dollar returns
The Aclaris Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Aclaris Therapeutics Inc investment value today
Current value as on today
₹4,07,501
Returns
₹3,07,501
(+307.5%)
Returns from Aclaris Therapeutics Inc Stock
₹2,72,807 (+272.81%)
Dollar Impact
₹34,694 (+34.69%)
Analyst Recommendation on Aclaris Therapeutics Inc Stock
Based on 15 analysts
40.00%
Buy
60.00%
Hold
0.00%
Sell
Based on 15 analysts, 60% of analysts recommend a 'HOLD' rating for Aclaris Therapeutics Inc. Average target price of $8.5
Aclaris Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Aclaris Therapeutics Inc.
What analysts predicted
50%UPSIDE
Target Price
$8.5
Current Price
$4.25
Analyzed by
15 Analysts
Target
$8.50
Aclaris Therapeutics Inc target price $8.5, a slight upside of 50% compared to current price of $4.25. According to 15 analysts rating.
Aclaris Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Aclaris Therapeutics Inc Stock has increased by 116% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:116% versus previous 30 day period
Aclaris Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Aclaris Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Aclaris Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Aclaris Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Aclaris Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, ACRS has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 6 months, ACRS stock has moved up by 78.6%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 78.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -14.61M → -19.79M (in $), with an average decrease of 35.5% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 3.29M → 1.29M (in $), with an average decrease of 60.8% per quarter
About Aclaris Therapeutics Inc
| Organisation | Aclaris Therapeutics Inc |
| Headquarters | 701 Lee Road, Wayne, PA, United States, 19087 |
| Industry | Biotechnology |
| CEO | Dr. Neal S. Walker D.O., M.D. |
| E-voting on shares | Click here to vote |
Key Management of Aclaris Therapeutics Inc
Name | Title |
|---|---|
Dr. Hugh M. Davis Ph.D. | President, COO & Director |
Mr. Kevin Balthaser | Chief Financial Officer |
Dr. Roland Kolbeck Ph.D. | Chief Scientific Officer |
Mr. Matthew Rothman J.D. | General Counsel & Corporate Secretary |
Dr. Jon Jacobsen Ph.D. | Senior Vice President of Chemistry |
Dr. Neal S. Walker D.O., M.D. | Co-Founder, CEO & Chairman |
Mr. James Loerop | Chief Business Officer |
Mr. William C. Roberts | Senior VP of Corporate Communications & Investor Relations |
Mr. Steve Tucker | Executive Vice President of Project Leadership |
Dr. Jesse W. Hall M.D. | Chief Medical Officer |
FAQs
What is Aclaris Therapeutics Inc share price today?
Aclaris Therapeutics Inc share price today is $4.25 as on at the close of the market. Aclaris Therapeutics Inc share today touched a day high of $4.32 and a low of $4.17.
What is the 52 week high and 52 week low for Aclaris Therapeutics Inc share?
Aclaris Therapeutics Inc share touched a 52 week high of $4.89 on and a 52 week low of $1.1 on . Aclaris Therapeutics Inc stock price today i.e. is closed at $4.25,which is 13.09% down from its 52 week high and 288.13% up from its 52 week low.
What is Aclaris Therapeutics Inc's market capitalisation today?
Aclaris Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Aclaris Therapeutics Inc Stock (ACRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aclaris Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aclaris Therapeutics Inc Shares that will get you 0.3529 shares as per Aclaris Therapeutics Inc share price of $4.25 per share as on April 21, 2026 at 1:29 am IST.
What is the minimum amount required to buy Aclaris Therapeutics Inc Stock (ACRS) from India?
Indian investors can start investing in Aclaris Therapeutics Inc (ACRS) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in Aclaris Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aclaris Therapeutics Inc share’s latest price of $4.25 as on April 21, 2026 at 1:29 am IST, you will get 2.3529 shares of Aclaris Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Aclaris Therapeutics Inc has given to Indian investors in the last 5 years?
Aclaris Therapeutics Inc stock has given -83.94% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?